FIELD: medicine.
SUBSTANCE: invention refers to peptide melanocortin receptor ligands, particularly melanocortin-4 receptor.
EFFECT: higher clinical effectiveness in diseases reacting on activation of the given receptor, eg obesity, diabetes and sexual dysfunction.
13 cl, 7 dwg, 7 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF MELANOCORTIN FOR TREATING INSULIN SENSITIVITY | 2008 |
|
RU2453328C2 |
MELANOCORTIN RECEPTOR LIGANDS | 2006 |
|
RU2439079C2 |
MELANOCORTIN RECEPTOR LIGANDS | 2006 |
|
RU2380372C2 |
LIGANDS OF MELANOCORTIN RECEPTORS | 2006 |
|
RU2401841C2 |
METHOD FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCORTIN 4 RECEPTOR PATH | 2016 |
|
RU2785889C1 |
ALPHA- AND GAMMA-MSH ANALOGUES | 2013 |
|
RU2668791C2 |
PEPTIDE COMPOSITIONS | 2014 |
|
RU2725150C2 |
PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
ANALOGUES OF PEPTIDE LH-RF, THEIR APPLICATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 1998 |
|
RU2212247C2 |
PEPTIDE VECTORS | 2004 |
|
RU2361876C2 |
Authors
Dates
2012-05-10—Published
2008-05-23—Filed